Blog

Feb
22
2019

AIM Science Advisory Chair Receives ICFSR Lifetime Achievement Award

February 21, 2019 – Aging in Motion’s Science Advisory Board Chair, Jack Guralnik, M.D., Ph.D., MPH, received a Lifetime Achievement Award during a ceremony at the International Conference for Frailty and Sarcopenia Research (ICFSR) in Miami Beach, Florida.

The ICFSR Lifetime Achievement Award recognizes researchers that have greatly... Read more »

Apr
20
2017

PFDD Sarcopenia Meeting Update

On April 6, the U.S. Food and Drug Administration (FDA) held its public meeting on Patient-Focused Drug Development (PFDD) for sarcopenia. The focus of the meeting was to obtain patient perspectives on “symptoms and the daily impacts of their condition, current approaches to treatment, and decision factors taken into account when... Read more »

Feb
2
2017

FDA Seeks Patient Perspectives on Sarcopenia

Do you or a loved one have sarcopenia? Or are you curious to understand more about how sarcopenia could impact you? The U.S. Food and Drug Administration wants to hear from you. On April 6, 2017, from 1 to 4 p.m. EST, the FDA will... Read more »

Dec
15
2016

AIM Coalition Hosts Second Annual Meeting

On December 1, the Aging in Motion (AIM) Coalition hosted its second annual meeting in Bethesda, Md., to discuss developments and advances in clinical research and treatment of sarcopenia. The meeting’s theme was “Advancing Therapeutic Development for Sarcopenia: Efforts to Improve Clinical Detection and Endpoint Measures,” which offered updates for stakeholders... Read more »

Aug
22
2016

AIM’s Bens Presents at August PDUFA VI Public Meeting

AIM Executive Director Cynthia Bens was invited by the U.S. Food and Drug Administration (FDA) to speak on two panels at an August 15 public meeting focused on the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA). A few weeks ago, the FDA released its Read more »